Adimmune Corporation

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022🗂️ Report periods on file: 2022, 2020

In its 2022 reporting, Adimmune Corporation disclosed greenhouse gas emissions of 17.3K tonCO2e/year. By scope: Scope 1: 5.2K tonCO2e/year; Scope 2: 12.1K tonCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
17.3K tonCO2e/year
2022
💧
Water Usage
156.64 ML/year
2022
♻️
Waste
531.15 tons/year
2022
⚙️
Energy Use
178.2K GJ/year
2022

📊 Emissions by Scope (2022)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).5.2K tonCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.12.1K tonCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
202217.3K tonCO2e/year

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Maintain zero honesty or ethics violation incidents
  • Maintain zero illegal incidents
  • Introduce a greenhouse gas inventory system as per ISO 14064-1
  • Obtain CNS 45001 certification
  • Maintain zero major work-related injuries or ill health

📅 Medium-term

  • Obtain ISO 14064-1 certification
  • Achieve net-zero emissions
  • Maintain ISO 14001 environmental management system
  • Create a workplace free of occupational accidents

🌱 ESG Focus Areas

Corporate GovernanceSocial ResponsibilityProduct LiabilityEnvironmental Sustainability

⚠️ Challenges & Risks +

  • Market and sales risks (dependence on government tenders, limited market size, seasonal demand)
  • Product quality and safety risks
  • Law change risks (stringent pharmaceutical regulations)
  • Supply chain and procurement risks (limited suppliers, raw material shortages)
  • Occupational health and safety risks
  • Climate risks (extreme weather, regulatory changes, market shifts)

📋 Report Information

Reporting Period: 2022
Frameworks: GRI Universal Standards 2021, SASB, TCFD